ArticleExperimental and therapeutic medicine2015
Hypoxia-inducible factor-1α antagonizes the hypoxia-mediated osteoblast cell viability reduction by inhibiting apoptosis.
Article in Experimental and therapeutic medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 9 citations in OpenAlex.
- Gastric Mucosal Lesions in Tibetans with High-Altitude Polycythemia Show Increased HIF-1A Expression and ROS Production.BioMed research international · 2019Trial
- Review
- HIF-1α at the intersection of hypoxia, ferroptosis-associated stress, and cell death crosstalk in osteomyelitis.Frontiers in cell and developmental biology · 2026Review
- Hypoxia inducible factor-1α related mechanism and TCM intervention in process of early fracture healing.Chinese herbal medicines · 2024Review
- Mesenchymal stem cells: amazing remedies for bone and cartilage defects.Stem cell research & therapy · 2020Review
- Bone biology in postnatal Wistar rats following hypoxia-reoxygenation.Histology and histopathology · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bone fracture is accompanied with poor oxygen supply and nutrient deficiency in the local fracture site, and oxygen supply is an important factor that can affect fracture healing. Hypoxia-inducible factor-1 (HIF-1) plays a key role in the regulation of oxygen homeostasis. HIF-1α is rapidly upregulated in response to hypoxia and antagonizes hypoxia-induced apoptosis. In the present study, the viability of an osteoblast cell line, MC3T3-E1, and the expression of HIF-1α protein in the MC3T3-E1 cells was examined under hypoxic conditions. The HIF-1α level was then manipulated and the reduction in the viability of the MC3T3-E1 cells in response to the hypoxia was re-evaluated. In addition, the regulation of HIF-1α in the adaptation of MC3T3-E1 cells to hypoxia was explored. The results showed that the viability of MC3T3-E1 cells decreased and the expression of HIF-1α protein increased under hypoxic conditions. Furthermore, the reduction in the viability of MC3T3-E1 cells post-hypoxia was attenuated by HIF-1α overexpression, while HIF-1α-knockdown by small interfering RNA enhanced the hypoxia-induced decrease in cell viability. It was additionally found that the forced expression of HIF-1α inhibited the hypoxia-induced cell apoptosis. These findings indicate that the forced expression of HIF-1α inhibits hypoxia-induced apoptosis and thus attenuates the hypoxia-induced decrease in cell viability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.